Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


User error

This article was originally published in The Gray Sheet

Executive Summary

FDA-sponsored satellite teleconference scheduled for Oct. 11 from 1:00-3:00 (EDT) will "help the medical device industry incorporate user needs into their design and development" plans, announcement posted at states

You may also be interested in...

User error

FDA-sponsored satellite teleconference scheduled for Oct. 11 on device user error has been postponed until Feb. 14, 2001, the agency says (1"The Gray Sheet" Sept. 4, 2000, p. 2). The meeting is intended to aid incorporation of user needs into design and development plans. For more information, check

Teva Plans To Appeal EU Provigil Fine

Teva plans to begin appeal proceedings, the firm has told Generics Bulletin, after being fined €60.5m ($72m) by the European Commission over an historic “pay-for-delay” arrangement covering subsidiary firm Cephalon’s Provigil (modafinil).




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts